429 related articles for article (PubMed ID: 25579574)
1. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.
Shameer K; Readhead B; Dudley JT
Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574
[TBL] [Abstract][Full Text] [Related]
2. A survey of current trends in computational drug repositioning.
Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
[TBL] [Abstract][Full Text] [Related]
3. Computational drug repositioning for rare diseases in the era of precision medicine.
Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
[TBL] [Abstract][Full Text] [Related]
4. Computational and Practical Aspects of Drug Repositioning.
Oprea TI; Overington JP
Assay Drug Dev Technol; 2015; 13(6):299-306. PubMed ID: 26241209
[TBL] [Abstract][Full Text] [Related]
5. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
6. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
Kwon OS; Kim W; Cha HJ; Lee H
Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
[TBL] [Abstract][Full Text] [Related]
7. Drug repositioning for rare diseases: Knowledge-based success stories.
Scherman D; Fetro C
Therapie; 2020 Apr; 75(2):161-167. PubMed ID: 32164975
[TBL] [Abstract][Full Text] [Related]
8. eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.
Brylinski M; Naderi M; Govindaraj RG; Lemoine J
J Mol Biol; 2018 Jul; 430(15):2266-2273. PubMed ID: 29237557
[TBL] [Abstract][Full Text] [Related]
9. Rare Diseases: Drug Discovery and Informatics Resource.
Zhao M; Wei DQ
Interdiscip Sci; 2018 Mar; 10(1):195-204. PubMed ID: 29094320
[TBL] [Abstract][Full Text] [Related]
10. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
Yang CC; Zhao M
Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
[TBL] [Abstract][Full Text] [Related]
11. MD-Miner: a network-based approach for personalized drug repositioning.
Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
[TBL] [Abstract][Full Text] [Related]
12. The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases - recommendations of the IRDiRC Data Mining and Repurposing Task Force.
Southall NT; Natarajan M; Lau LPL; Jonker AH; Deprez B; Guilliams T; Hunter L; Rademaker CM; Hivert V; Ardigò D;
Orphanet J Rare Dis; 2019 Oct; 14(1):225. PubMed ID: 31615551
[TBL] [Abstract][Full Text] [Related]
13. A review of network-based approaches to drug repositioning.
Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR
Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136
[TBL] [Abstract][Full Text] [Related]
14. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Alaimo S; Pulvirenti A
Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
[TBL] [Abstract][Full Text] [Related]
15. Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases.
Xu K; Coté TR
Brief Bioinform; 2011 Jul; 12(4):341-5. PubMed ID: 21357612
[TBL] [Abstract][Full Text] [Related]
16. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Cheng F; Hong H; Yang S; Wei Y
Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
[TBL] [Abstract][Full Text] [Related]
17. A Review of Recent Developments and Progress in Computational Drug Repositioning.
Shi W; Chen X; Deng L
Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
[TBL] [Abstract][Full Text] [Related]
18. Drug repositioning for orphan diseases.
Sardana D; Zhu C; Zhang M; Gudivada RC; Yang L; Jegga AG
Brief Bioinform; 2011 Jul; 12(4):346-56. PubMed ID: 21504985
[TBL] [Abstract][Full Text] [Related]
19. A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions.
Jarada TN; Rokne JG; Alhajj R
J Cheminform; 2020 Jul; 12(1):46. PubMed ID: 33431024
[TBL] [Abstract][Full Text] [Related]
20. Uncovering novel repositioning opportunities using the Open Targets platform.
Khaladkar M; Koscielny G; Hasan S; Agarwal P; Dunham I; Rajpal D; Sanseau P
Drug Discov Today; 2017 Dec; 22(12):1800-1807. PubMed ID: 28919242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
